Backers included existing investors Khosla Ventures and True Ventures, and new strategic investors.
The company plans to use the funds to scale its commercial relationships, expand emergent digital therapies and continue to build its team of data scientists, application engineers, healthcare experts and user experience designers.
Led by Dr. Anmol Madan, co-founder and CEO, Ginger.io provides a machine learning technology platform (developed at the MIT Media Lab) that uses smartphone data and self-reported information to identify trends in a patient’s health and wellness. That insight is then shared with healthcare providers and care teams (such as spouses or family members) when the patient trends toward a negative health outcome, enabling effective interventions that can reduce patient readmissions and visits to high-cost care settings, such as emergency departments.
The company is currently working with leading U.S. healthcare institutions including UCSF, Novant Health and Centerstone/CRI.